Hydrocortisone switch showed a tradeoff between cholesterol and hormone control
Among patients with congenital adrenal hyperplasia, cholesterol improved after switching to dual-release hydrocortisone, but hormone control tended to worsen. This retrospective comparison cannot establish that the switch caused either change.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
After patients switched formulations, total and LDL cholesterol were lower, while hormone control tended to deteriorate despite higher hydrocortisone-equivalent doses. Glucose measures showed no significant change. These mixed results concern patients with classic congenital adrenal hyperplasia and do not establish a broader health benefit or justify a medication change.
This was a small retrospective comparison without a separate concurrent control group. Cholesterol changes are laboratory outcomes; the abstract does not demonstrate fewer cardiovascular events or establish long-term safety.
What researchers found
Proportion classified as having good disease control
Previous treatment versus dual-release hydrocortisone at the last available visit: 5/17 (29%) versus 1/17 (6%); p = 0.07.
Different outcomes moved in different directions
Lower cholesterol did not coincide with better hormonal control. The decline in the proportion with good disease control was not statistically significant, so its size and reliability remain uncertain despite the observed pattern.
Stopping treatment and safety observations
Unsatisfactory disease control was the main reason for discontinuation in 11/17 patients after a median of 26 months. No adrenal crises were recorded during follow-up, but that observation alone does not establish safety.
The original publication
Impact of dual-release hydrocortisone on disease control and metabolism in congenital adrenal hyperplasia: a retrospective cohort study.
Mazzeo P, Tizianel I, Sabbadin C et al.
Endocrine · 2025
- PubMed ID
- 40603719
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.